Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology

Exp Physiol. 2011 Sep;96(9):863-74. doi: 10.1113/expphysiol.2011.056994. Epub 2011 Jun 17.


Myocardial infarction (MI) results in cell death, development of interstitial fibrosis, ventricular wall thinning and ultimately, heart failure. Angiotensin-(1-7) [Ang-(1-7)] has been shown to provide cardioprotective effects. We hypothesize that lentivirus-mediated overexpression of Ang-(1-7) would protect the myocardium from ischaemic injury. A single bolus of 3.5 × 10(8) transducing units of lenti-Ang-(1-7) was injected into the left ventricle of 5-day-old male Sprague-Dawley rats. At 6 weeks of age, MI was induced by ligation of the left anterior descending coronary artery. Four weeks after the MI, echocardiography and haemodynamic parameters were measured to assess cardiac function. Postmyocardial infarction, rats showed significant decreases in fractional shortening and dP/dt (rate of rise of left ventricular pressure), increases in left ventricular end-diastolic pressure, and ventricular hypertrophy. Also, considerable upregulation of cardiac angiotensin-converting enzyme (ACE) mRNA was observed in these rats. Lentivirus-mediated cardiac overexpression of Ang-(1-7) not only prevented all these MI-induced impairments but also resulted in decreased myocardial wall thinning and an increased cardiac gene expression of ACE2 and bradykinin B2 receptor (BKR2). Furthermore, in vitro experiments using rat neonatal cardiac myocytes demonstrated protective effects of Ang-(1-7) against hypoxia-induced cell death. This beneficial effect was associated with decreased expression of inflammatory cytokines (tumour necrosis factor-α and interleukin-6) and increased gene expression of ACE2, BKR2 and interleukin-10. Our findings indicate that overexpression of Ang-(1-7) improves cardiac function and attenuates left ventricular remodelling post-MI. The protective effects of Ang-(1-7) appear to be mediated, at least in part, through modulation of the cardiac renin-angiotensin system and cytokine production.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / genetics*
  • Angiotensin I / therapeutic use*
  • Angiotensin-Converting Enzyme 2
  • Animals
  • Interleukin-10 / biosynthesis
  • Interleukin-6 / biosynthesis
  • Lentivirus / genetics
  • Male
  • Myocardial Ischemia / prevention & control*
  • Myocardium / metabolism
  • Peptide Fragments / genetics*
  • Peptide Fragments / therapeutic use*
  • Peptidyl-Dipeptidase A / biosynthesis
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Bradykinin B2 / biosynthesis
  • Renin-Angiotensin System / physiology
  • Transduction, Genetic
  • Ventricular Remodeling


  • Interleukin-6
  • Peptide Fragments
  • Receptor, Bradykinin B2
  • Interleukin-10
  • Angiotensin I
  • Peptidyl-Dipeptidase A
  • Ace2 protein, rat
  • Angiotensin-Converting Enzyme 2
  • angiotensin I (1-7)